Prospective assessment for the development of radiation-induced lung injury after stereotactic radiotherapy

Prospective assessment for the development of radiation-induced lung injury after stereotactic radiotherapy - Radiation-induced lung injury after stereotactic radiotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000033898

Enrollment

Registered

2018-08-27

Start date

2018-08-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients who are scheduled for stereotactic radiotherapy for primary lung cancer. 2.tumor diameter:5 cm >=

Exclusion criteria

Exclusion criteria: 1. Patients who are not suitable for using a contrast medium because of renal function or allergy. 2. Pregnant or lactating woman, likelihood of pregnancy 3. Radiation oncologist judged that the patient was not suitable for stereotactic radiotherapy 4. Critical mental disturbance

Design outcomes

Primary

Measure	Time frame
The grading of radiation-induced lung injury, hypoxia and dyspnea at baseline, 1 month, 4 month and 12 month after stereotactic radiotherapy.	—

Secondary

Measure	Time frame
The assessment of lung function using spirometry, perfusion CT, 4-D CT, BMI and fat-free mass index at baseline, 1 month, 4 months and 12 month after stereotactic radiotherapy.	—

Countries

Japan

Contacts

Public ContactSee above See above

See above See above

t.yamamoto@rad.med.tohoku.ac.jp+81-22-717-7312

Outcome results